[Experimentation in persons wtih a neurodegenerative disease]

Area of Science:

• Neurology
• Bioethics
• Clinical Research

Context:

• Neurodegenerative diseases, such as Alzheimer's disease, are increasingly researched.
• Ethical and legal considerations for patient participation in clinical trials are crucial.
• Current research involves subjects who may lose decision-making capacity during the study.

Purpose:

• To explore the legal and ethical permissibility of continuing experiments with individuals who develop incapacity during a study.
• To examine the role of legal representatives in providing consent for incapacitated participants.
• To assess the implications of advance directives and legal mandates on research continuity.

Summary:

• Clinical trials for neurodegenerative diseases can commence when a patient is capable and continue beyond the point of incapacity.
• The law permits adults incapable of providing consent to participate in research.
• Consent for incapacitated individuals must be obtained from their legal representative (e.g., mandatary, tutor, curator).
• A mandate given in anticipation of incapacity designates a representative (mandatary) to act on the individual's behalf.
• This mandate minimizes research disruption, limiting interruptions to a few weeks due to incapacity.

Impact:

• Facilitates ongoing research in neurodegenerative diseases by ensuring participant continuity.
• Upholds ethical standards by defining clear consent pathways for vulnerable populations.
• Provides a legal framework for the continuation of vital medical research despite patient cognitive decline.